The Oxford Science Park (TOSP)’s Post

#Cytiva & #LevitasBio team up for streamlined #singlecell workflow: Combining Cytiva's Via Extractor (tissue dissociation) with LevitasBio's LeviCell (isolation & #enrichment solution), to offer a new, #automated solution for single-cell #genomics research. https://shorturl.at/jtHKP

Have you watched our latest video on Dose Response Curves? 👀👏🧬 Dose-response curves are graphical representations of the relationship between the concentration or dose of a drug or compound and its biological response. In drug discovery, these curves are used to assess the potency and efficacy of a drug candidate. Watch the full video on our YouTube channel: https://lnkd.in/ejTKB3aW #IDOT #Technology #Automation #LifeSciences #LiquidHandling #LabAutomation #Development #DrugDiscovery #Genomics #SyntheticBiology #LaboratoryAutomation #FutureOfHealth

A picture speaks a thousand words... .........and so does an INFOGRAPHIC 📈 for bringing your scientific innovations in front of the eyes of potential investors and leads! ✅ Check this post to learn how infographics can power your biotech business marketing. Do you want a FREE Guide on "How to Create a Powerful Infographic for Marketing Your Biotech Business"? Please DM your business email address or write to us at info@genedent.com with the subject POWERGRAPHIC. #infographic #digitalmarketing #infographicservice #healthstartups #kroynas #biotechnology #biotech #biotechindustry #lifescienceindustry #biotechstartups #lifescienceindustry #research #clinicaltrial #aptamers #3dprinting #genetics #genomics #oncology #immunology

#PrecisionTherapies are rapidly advancing, targeting #DNA, RNA, proteins, and more to provide multiomic and curative treatments. Our research at ARK Investment Management LLC suggests that the value of companies focused on precision therapies could grow by 28% annually over the next seven years, increasing from around $820 billion in 2023 to approximately $4.5 trillion by 2030. In this video, Brett Winton (our Chief Futurist) explains why this decade will be a game-changer for healthcare and investment opportunities. Capital at Risk. #ARKInvest #ActiveETFs #Genomics #ThematicInvesting

The development of a new drug is a complex, time-consuming, and costly process that takes an average of 10-15 years and costs anywhere from $1-2.5 billion USD. A significant component of the drug discovery process involves assessing various drug properties through robust assays. Read the full blog here: https://lnkd.in/dt5Pcu4m #IDOT #Technology #Automation #LifeSciences #LiquidHandling #LabAutomation #Development #DrugDiscovery #Genomics #SyntheticBiology #LaboratoryAutomation #FutureOfHealth

Design of experiments (DoE) for drug discovery assays is a statistical and systematic approach used to optimize the experimental conditions and parameters in the drug discovery process. It involves strategically planning and conducting experiments to understand the relationship between multiple variables and their impact on the assay outcome. Read more about DoE here: https://lnkd.in/gnn6tmDw #IDOT #Technology #Automation #LifeSciences #LiquidHandling #LabAutomation #Development #DrugDiscovery #Genomics #SyntheticBiology #LaboratoryAutomation #FutureOfHealth

The development of a new drug is a complex, time-consuming, and costly process that takes an average of 10-15 years and costs anywhere from $1-2.5 billion USD. A significant component of the drug discovery process involves assessing various drug properties through robust assays. Read the full blog here: https://lnkd.in/dt5Pcu4m #IDOT #Technology #Automation #LifeSciences #LiquidHandling #LabAutomation #Development #DrugDiscovery #Genomics #SyntheticBiology #LaboratoryAutomation #FutureOfHealth

InVitria, Inc. is attending #ASGCT24 in Baltimore! We will be located at Booth 131. Stop by to learn how our sustainable recombinant technology has been implemented by #celltherapy and #genetherapy developers to enhance biomanufacturing and final formulation! Connect with us through the event meeting portal to schedule a meeting. Team Members attending include: Andrew Hamann, PhD, Mark Stathos, Ph.D., Jake Hanks, Marcus Curl, Elliott Renft, Colin Odishoo, and Scott Deeter. Here's how InVitria's innovations contribute to success: Sustainability A steadfast focus on reducing the environmental impact and ensuring a sustainable and ethical supply of critical components for clinical applications. Safety and Quality Our commitment to animal-free components significantly reduces the risk of contaminants and ensures higher manufacturing consistency. Performance Enhanced cell growth, productivity, and product yield, facilitating faster and more efficient production cycles. We believe these solutions are pivotal to a future where cell and gene therapy achieve their promise for patients. They are not just a step towards more ethical and sustainable practices but also a leap towards more reliable and efficient therapeutic production. #SustainableSolutions #CellTherapies #GeneTherapies #AnimalFree #CharmCity

Design of experiments (DoE) for drug discovery assays is a statistical and systematic approach used to optimize the experimental conditions and parameters in the drug discovery process. It involves strategically planning and conducting experiments to understand the relationship between multiple variables and their impact on the assay outcome. Read more about DoE here: https://lnkd.in/gE7NHZZm #IDOT #Technology #Automation #LifeSciences #LiquidHandling #LabAutomation #Development #DrugDiscovery #Genomics #SyntheticBiology #LaboratoryAutomation #FutureOfHealth

Design of experiments (DoE) for drug discovery assays is a statistical and systematic approach used to optimize the experimental conditions and parameters in the drug discovery process. It involves strategically planning and conducting experiments to understand the relationship between multiple variables and their impact on the assay outcome. Read more about DoE here: https://lnkd.in/g2Ca67tz #IDOT #Technology #Automation #LifeSciences #LiquidHandling #LabAutomation #Development #DrugDiscovery #Genomics #SyntheticBiology #LaboratoryAutomation #FutureOfHealth